ExSight Ventures

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
The average size of a deal this fund participated in
Portfolio companies 6
Rounds per year 1.50
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees 5
Stages of investment
Early Stage Venture

Areas of investment

  • Therapeutics
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical

ExSight Ventures appeared to be the VC, which was created in 2014. The main office of represented VC is situated in the New York. The venture was found in North America in United States.

The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Genetics, Biotechnology. Among the various public portfolio startups of the fund, we may underline ONL Therapeutics, RetroSense Therapeutics, lensgen Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. Comparing to the other companies, this ExSight Ventures performs on 9 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 5 participants. Despite the ExSight Ventures, startups are often financed by National Institutes of Health, MedTech Innovator, Tech Coast Angels. The meaningful sponsors for the fund in investment in the same round are InFocus Capital Partners, Hatteras Venture Partners, Aju IB Investment. In the next rounds fund is usually obtained by InFocus Capital Partners, HOYA Group, Invest Michigan.

We also calculated 5 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of ExSight Ventures:
Typical Co-investors
ExSight Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after ExSight Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A/O Proptech England, London, United Kingdom
Alzheimer's Foundation of America New York, New York, United States
Arali Ventures Bangalore, India, Karnataka
Camas Investments -
Efficient Networks Dallas, Texas, United States
Elevat3 Capital -
Guangdong Bobaolon China, Guangdong Province, Jieyang City
Guojing Touzi -
International Copper Association -
Juroku Lease Gifu, Gifu Prefecture, Japan
Lowenthal Capital Partners California, Davis, United States
McKnight Foundation -
MLV & Co. New York, New York, United States
Nogle Group -
Pingan Caizhi China, Guangdong, Shenzhen
Red Dog Capital California, Palo Alto, United States
Tfund Connecticut, United States, Wallingford
Tracsis England, Leeds, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

DTx Pharma

$100M01 Mar 2021 San Diego, California, United States

ONL Therapeutics

$46M22 Dec 2020 Ann Arbor, Michigan, United States

Re-Vana Therapeutics

Health Care
Market Research
$3M02 Jun 2020 Northern Ireland

DTx Pharma

$10M06 Jan 2020 San Diego, California, United States

Trefoil Therapeutics

Health Care
$28M16 Jul 2019 San Diego, California, United States

ONL Therapeutics

$4M17 May 2017 Ann Arbor, Michigan, United States


Health Care
Medical Device
$21M01 May 2017 Irvine, California, United States

Trefoil Therapeutics

Health Care
$5M05 Jan 2017 San Diego, California, United States

RetroSense Therapeutics

Life Science
$6M12 Nov 2015 Ann Arbor, Michigan, United States
DTx Pharma Closes $100M Series B Financing

– DTx Pharma, Inc. from San Diego raised $100m in Series B financing.
– The round was led by RA Capital Management with participation from new investors Access Biotechnology, Surveyor Capital (a Citadel company), Cormorant Asset Management, Janus Henderson Investors, and Logos Capital and existing investors Friedman Bioventure Fund, Eli Lilly and Company, Viva BioInnovator (Viva Biotech Holdings, 1873.HK), and ExSight Ventures.
– The company intends to use the funds to utilize its FALCON fatty acid motifs to advance assets into clinical development across several therapeutic areas over the next few years.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ExSight Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: